Loading...
Loading...
India's serum imports from GERMANY total $6.7M across 235 shipments from 15 foreign suppliers. Biotest Ag leads with $4.1M in import value; the top 5 suppliers together control 97.6% of this origin. Leading Indian buyers include PAVIOUR PHARMACEUTICALS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for serum — a diversified sourcing base with multiple active suppliers from GERMANY.

Biotest Ag is the leading Serum supplier from GERMANY to India, with import value of $4.1M across 13 shipments. The top 5 suppliers — Biotest Ag, BIOTEST AG, CAPRICORN SCIENTIFIC GMBH, PEKANA NATURHEILMITTEL GMBH, DEUTSCHE HOMOOPATHIE-UNION — collectively account for 97.6% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | Biotest Ag | $4.1M | 13 | 61.5% |
| 2 | BIOTEST AG | $1.4M | 17 | 20.5% |
| 3 | CAPRICORN SCIENTIFIC GMBH | $841.3K | 81 | 12.6% |
| 4 | PEKANA NATURHEILMITTEL GMBH | $102.5K | 6 | 1.5% |
| 5 | DEUTSCHE HOMOOPATHIE-UNION | $98.9K | 12 | 1.5% |
| 6 | M S OCTAPHARMA AG | $48.7K | 1 | 0.7% |
| 7 | ROCHE DIAGNOSTICS INTERNATIONAL LTD | $26.1K | 23 | 0.4% |
| 8 | Merck Life Science KGaA | $20.2K | 26 | 0.3% |
| 9 | BIOPHYLL GMBH | $15.9K | 3 | 0.2% |
| 10 | BIOGENES GMBH | $14.7K | 1 | 0.2% |
| 11 | SERANA EUROPE GMBH | $11.0K | 6 | 0.2% |
| 12 | SYNAPTIC SYSTEMS GMBH | $4.1K | 14 | 0.1% |
| 13 | CAPRICORN SCIENTIFIC | $4.1K | 2 | 0.1% |
| 14 | SYNAPTIC SYSTEMS | $3.1K | 12 | 0.0% |
| 15 | BIOMEX GMBH | $2.9K | 2 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PAVIOUR PHARMACEUTICALS PRIVATE LIMITED | $5.4M | 27 | 80.6% |
| 2 | SPARSHBIO | $368.3K | 33 | 5.5% |
| 3 | CLEARSYNTH LABS LIMITED | $249.0K | 1 | 3.7% |
| 4 | GENETIX BIOTECH ASIA PRIVATE LIMITED | $147.7K | 32 | 2.2% |
| 5 | GERMAN HOMOEOPATHIC DISTRIBUTORS PRIVATE LIMITED | $102.5K | 6 | 1.5% |
| 6 | DR WILLMAR SCHWABE INDIA PRIVATE LIMITED | $98.9K | 12 | 1.5% |
| 7 | PAVIOUR PHARMACEUTICALS PVT LTD | $95.8K | 2 | 1.4% |
| 8 | MP BIOMEDICALS INDIA PRIVATE LIMITED | $66.7K | 6 | 1.0% |
| 9 | BIOLOGICAL E LIMITED | $48.7K | 1 | 0.7% |
| 10 | ROCHE DIAGNOSTICS INDIA PRIVATE LIMITED | $27.0K | 25 | 0.4% |
| 11 | MERCK LIFE SCIENCE PRIVATE LIMITED | $20.2K | 26 | 0.3% |
| 12 | HIMEDIA LABORATORIES PRIVATE LIMITED | $20.0K | 5 | 0.3% |
| 13 | INTAS PHARMACEUTICALS LIMITED | $14.7K | 1 | 0.2% |
| 14 | DENSITY PHARMACHEM PRIVATE LIMITED | $10.5K | 1 | 0.2% |
| 15 | LABEX CORPORATION | $7.2K | 26 | 0.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Serum suppliers from GERMANY to India include Biotest Ag, BIOTEST AG, CAPRICORN SCIENTIFIC GMBH. The leading supplier is Biotest Ag with import value of $4.1M USD across 13 shipments. India imported Serum worth $6.7M USD from GERMANY in total across 235 shipments.
India imported Serum worth $6.7M USD from GERMANY across 235 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Serum sourced from GERMANY include PAVIOUR PHARMACEUTICALS PRIVATE LIMITED, SPARSHBIO, CLEARSYNTH LABS LIMITED. The largest buyer is PAVIOUR PHARMACEUTICALS PRIVATE LIMITED with $5.4M in imports across 27 shipments.
The total value of Serum imports from GERMANY to India is $6.7M USD, across 235 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
235 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists